Skip to main content
Clinical Trials/JPRN-UMIN000018319
JPRN-UMIN000018319
Not Yet Recruiting
N/A

Study on the efficacy of mechanical circulatory support (MCS) in acute coronary syndrome (ACS) complicated by cardiogenic shock or cardiac arrest - MCS and ACS

Kyushu university graduate school of medical sciences, Cardiovascular medicine0 sites80 target enrollmentJuly 15, 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
acute coronary syndrome
Sponsor
Kyushu university graduate school of medical sciences, Cardiovascular medicine
Enrollment
80
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 15, 2015
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Kyushu university graduate school of medical sciences, Cardiovascular medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 4
Clinical effect of promoting blood circulation and removing stasis on improving cognitive function of patients with hypertension arteriosclerosis and cerebral small vessel diseaseSmall cerebral vascular disease
ITMCTR2200006595The First Clinical Medical College of Beijing University of Chinese Medicine
Recruiting
N/A
Examination of the influence on the circulatory system by the airway management method using Nasal High Flow load device AIRVO during sedatio
JPRN-UMIN000041245agasaki University20
Completed
N/A
A study for improving effects on the blood flow and the skin by carbonate cosmeticsHealthy adults
JPRN-UMIN000025658Kao Corporation40
Active, Not Recruiting
N/A
Clinical investigation into efficacy, hemodynamics and tolerability of simvastatin vs placebo in patients with pulmonary arterial hypertension(Shorttitle: SIPHT)Double-blind, randomized, prospective Phase III-b study for 6 months with adjusting doses of simvastatin (40/80 mg daily) or placebo followed by an open-label period with a final dose of simvastatin 80 mg daily for another 6 months - SIPHTModified NYHA class II or III patients with Pulmonary Hypertension (PH), ICD: 416.9MedDRA version: 8.1Level: LLTClassification code 10020787Term: Hypertension pulmonary
EUCTR2005-004863-41-DEDept. of Internal Medicine II, University Hospital Giessen40
Completed
N/A
Clinical investigation into efficacy, haemodynamics and tolerability of simvastatin versus placebo in patients with pulmonary arterial hypertensioPulmonary hypertensionCirculatory SystemOther pulmonary heart diseases
ISRCTN27178415niversity Hospital Giessen (Germany)40